Bloodworks

Bloodworks, doing business as Puget Sound Blood Center and Program, is a Seattle-based tax-exempt nonprofit organization that provides blood donor testing, blood products, and specialty laboratory services as a prime contractor and federal grant recipient to the Department of Veterans Affairs, Defense Health Agency, Department of the Army, and the National Institutes of Health. The organization competes in unrestricted federal procurement with no set-aside designations across its prime contract footprint, which accounts for 94% of its 464 total awards.

Bloodworks' core federal capability centers on blood donor specimen testing (including infectious disease screening for syphilis, hepatitis, HIV, Chagas disease, West Nile virus, Babesia, and cytomegalovirus), reference laboratory services, and blood product supply to military and veterans' medical treatment facilities. Representative delivery orders include a $4.99 million indefinite-delivery contract from the Defense Health Agency (awarded March 1, 2024, with ultimate completion February 28, 2029) for blood donor testing at Madigan Army Medical Center in Lewis McChord, Washington; a $9.68 million indefinite-delivery contract from Veterans Integrated Service Network 20 (August 1, 2021) for blood products to the Puget Sound VA Medical Center; and a $3.28 million indefinite-delivery contract from VISN 12 (September 30, 2021) for blood donor testing at Captain James A. Lovell Federal Health Care Center in North Chicago, Illinois. Bloodworks also invoices through the Defense Health Agency for blood donor panel testing and infectious disease screening supplies serving Naval Hospital Guam and Tripler Army Medical Center.

Customer concentration is moderate but skews heavily toward VA networks and military medical commands. The top five customers account for 95% of combined potential value across 464 awards: Veterans Integrated Service Network 20 leads with 34 awards worth $70.4 million combined potential value; Department of the Army Medical Command accounts for 157 awards (the highest count) valued at $33.2 million; the Defense Health Agency holds 21 awards worth $27.7 million; the Department of Health and Human Services Health Resources and Services Administration anchors two awards at $21.6 million (likely grant-related); and VISN 12 carries 13 awards worth $6.9 million. The National Heart, Lung, and Blood Institute rounds out major funding with 32 awards spanning federally funded research and grant work.

Bloodworks holds four active indefinite-delivery contracts with the VA and Department of the Army serving as parent vehicles for task orders: the $4.99 million Defense Health Agency IDIQ for blood donor testing at MAMC; the $9.68 million VISN 20 IDIQ for blood products; the $3.28 million VISN 12 IDIQ for blood donor testing at Lovell FHCC; and the $625 thousand VISN 20 renal-testing IDIQ (awarded September 30, 2024). Task orders against Army BPAs W91YU015A0007 (13 orders), W81K0215A0026 (12 orders), and W91YU010A0008 (8 orders) provide secondary vehicles. Bloodworks competes full and open across all parent vehicles; no set-asides appear in the contract portfolio.

Activity volume has grown, with 21 awards in 2024 and 17 in 2025, but declined to 6 awards in 2026 (reflecting the typical lapse in new-award reporting as of mid-year). Thirteen awards worth $13.5 million combined potential value reach ultimate completion within the next twenty-four months, presenting recompete exposure centered on blood testing and product supply tasks at VISN facilities and Madigan Army Medical Center.

Bloodworks operates predominantly as a prime on both contracts and grants, with subcontractor engagement minimal. SCI-reported invoicing across federal service contracts subject to the $150,000 reporting threshold totaled $8.9 million over FY2022–FY2024: $529 thousand in FY2022 across 8.8 FTEs, $3.5 million in FY2023 across 19.1 FTEs, and $4.9 million in FY2024 across 15.7 FTEs. Government-paid hourly rates on SCI-captured prime contracts ranged from approximately $53/hour at the 10th percentile to $275/hour at the 90th percentile, with a median of $150/hour. Bloodworks self-performed 100% of labor across SCI-reportable prime contracts with no subcontractors named.

The organization also operates a significant federal grant footprint as a prime recipient under the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of General Medical Sciences (NIGMS). Recent NHLBI and NIGMS project grants—valued at $724,351 (NHLBI, Cardiovascular Diseases Research CFDA 93.837, awarded July 1, 2026), $504,644 (NIGMS Biomedical Research and Research Training CFDA 93.859, awarded August 15, 2025), and $465 thousand (NHLBI, Cardiovascular Diseases Research, awarded April 1, 2025)—fund in vitro and in vivo research into mechanisms of hemostasis, platelet dysfunction, and endothelial injury in traumatic brain injury, sepsis, sickle cell disease, and von Willebrand disease. Bloodworks also participates as a subrecipient on research grants administered by the University of Washington, Mayo Clinic, University of Maryland Baltimore, and others, contributing laboratory and blood-specimen analysis to multi-site NIH R01 and R35 programs focused on coagulopathy, vascular biology, and transfusion medicine.